Telpegfilgrastim Injection is an advanced therapy designed to stimulate the production of white blood cells, particularly beneficial for patients undergoing chemotherapy or suffering from conditions that cause neutropenia. This innovative product leverages the latest advancements in colony-stimulating factor (CSF) therapy to enhance immune system function and reduce the risk of infections. Developed by Amoytop Biotech, Telpegfilgrastim Injection ensures high bioavailability and prolonged action, offering patients a reliable and effective treatment option. Its development underscores our commitment to providing therapies that address unmet medical needs and improve patient quality of life. By incorporating Telpegfilgrastim Injection into treatment regimens, healthcare providers can offer improved supportive care for patients facing severe immune challenges.
Specialized in R&D and production of recombinant protein drugs, and committed to providing better solutions for viral hepatitis, malignant tumor and immunotherapy etc..
